Aprameya Engineering (NSE:APRAMEYA) EBIT : ₹62.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Aprameya Engineering EBIT?

Aprameya Engineering's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2024 was ₹62.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹62.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Aprameya Engineering's annualized ROC % for the quarter that ended in Mar. 2024 was 8.21%. Aprameya Engineering's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 11.91%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Aprameya Engineering's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2.70%.

Aprameya Engineering EBIT Historical Data

The historical data trend for Aprameya Engineering's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprameya Engineering EBIT Chart

Aprameya Engineering Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT

14.72

22.71

249.34

88.65

62.83

Aprameya Engineering Semi-Annual Data
	Mar20	Mar21	Mar22	Mar23	Mar24
EBIT	14.72	22.71	249.34	88.65	62.83

Competitive Comparison of Aprameya Engineering's EBIT

For the Medical Instruments & Supplies subindustry, Aprameya Engineering's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aprameya Engineering's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aprameya Engineering's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Aprameya Engineering EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹62.8 Mil.

Aprameya Engineering (NSE:APRAMEYA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Aprameya Engineering's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	62.496 * ( 1 - 24.79% )	/	( (488.992	+	655.819)	/ 2 )
=	47.0032416	/	572.4055
=	8.21 %

where

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	618.903	-	127.787	-	( 2.124	-	max(0, 297.987	-	555.978	+	2.124	))
=	488.992

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	756.042	-	96.747	-	( 3.476	-	max(0, 396.613	-	702.759	+	3.476	))
=	655.819

Note: The Operating Income data used here is one times the annual (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Aprameya Engineering's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	62.831	/	( ( (13.867 + max(423.35, 0))	+	(18.939 + max(599.281, 0)) )	/	2 )
=	62.831	/	( ( 437.217	+	618.22 )	/	2 )
=	62.831	/	527.7185
=	11.91 %

where Working Capital is:

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(417.963	+	78.821	+	56.935)	-	(127.787	+	0	+	2.5820000000001)
=	423.35

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(580.634	+	33.947	+	84.348)	-	(96.747	+	0	+	2.901)
=	599.281

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Aprameya Engineering's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	62.831	/	2329.575
	=	2.70 %

Aprameya Engineering EBIT Related Terms

Thank you for viewing the detailed overview of Aprameya Engineering's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Aprameya Engineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aprameya Engineering Ltd (NSE:APRAMEYA) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

908, 9th Floor, Venus Atlantis Corporate Park, Anandnagar, Prahladnagar, Ahmedabad, GJ, IND, 380015

Website

https://www.aelhealth.com

Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units ("ICU"), Neonatal Intensive Care Units ("NICU"), Pediatric Intensive Care Units ("PICU"), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as "Healthcare Infrastructure projects") in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.

Aprameya Engineering Headlines

No Headlines